NCT05344209
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Vestre Viken Health Trust Drammen, Akershus, Norway
Clinical trial condition
NSCLC Stage IV
Explore clinical trials studying NSCLC Stage IV. Study availability and eligibility vary by location and protocol.
54 public trials
21 recruiting studies
NSCLC Stage IV trial results
Not yet recruiting
Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg
NCT07298148
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Not yet recruiting
Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC
NCT07339839
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not yet recruiting
Cancer Patient Remote Monitoring for Timely Communication Study
NCT06623786
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not yet recruiting
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
NCT05859217
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- The University of Kansas Cancer Center - Westwood Kansas City, Kansas, United States
- The University of Kansas Cancer Center - Indian Creek Overland Park, Kansas, United States
- The University of Kansas Cancer Center - North Kansas City, Missouri, United States
- The University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States
Not yet recruiting
Exercise in Patients With Advanced Non-small Cell Lung Cancer
NCT06374160
- Conditions
- Advanced Lung Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
- Locations
-
- West German Cancer Center (Department of Palliative medicine and Department of Medical Oncology), University Hospital Essen Essen, North Rhine-Westphalia, Germany
Not yet recruiting
HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC
NCT06218940
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not yet recruiting
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome
NCT05597800
- Conditions
- Bronchial Neoplasms, COVID-19, Carcinoma, Bronchogenic, +28 more
- Locations
-
- Centro Ricerche Cliniche Verona, Veneto/Verona, Italy
Active, not recruiting
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
NCT05673187
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Instiute Jules Bordet Brussels, Belgium
- Le Mans - CHG Le Mans, France
- Hôpital de Marseille Marseille, France
- Beaumont Hospital Dublin, Ireland
Active, not recruiting
Plasma-Adapted First-Line Pembro In NSCLC
NCT04166487
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Boston Medical Center Boston, Massachusetts, United States
- Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States